Brain-Specific Expression of Vascular Endothelial Growth Factor 146 Correlates with the Blood-Brain Barrier Induction in Quail Embryos

2008 ◽  
Vol 30 (5) ◽  
pp. 331-339 ◽  
Author(s):  
Eiji Ikeda ◽  
Keiyo Takubo ◽  
Takahide Kodama ◽  
Yasunori Okada
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Growth Factor ◽  
Blood Brain Barrier ◽  
Brain Barrier ◽  
Vascular Endothelial ◽  
Specific Expression ◽  
Blood Brain ◽  
Endothelial Growth Factor

scholarly journals Vascular Endothelial Growth Factor 165-Binding Heparan Sulfate Promotes Functional Recovery From Cerebral Ischemia

Stroke ◽  
2020 ◽  
Vol 51 (9) ◽  
pp. 2844-2853 ◽  
Author(s):  
Su Jing Chan ◽  
Elga Esposito ◽  
Kazuhide Hayakawa ◽  
Emiri Mandaville ◽  
Raymond A.A. Smith ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Endothelial Cell ◽  
Growth Factor ◽  
Blood Brain Barrier ◽  
Neural Progenitor Cells ◽  
Brain Barrier ◽  
Vascular Endothelial ◽  
Brain Endothelial Cell ◽  
Blood Brain ◽  
Endothelial Growth Factor

Background and Purpose: Although VEGF 165 (vascular endothelial growth factor-165) is able to enhance both angiogenesis and neurogenesis, it also increases vascular permeability through the blood-brain barrier. Heparan sulfate (HS) sugars play important roles in regulating VEGF bioactivity in the pericellular compartment. Here we asked whether an affinity-purified VEGF 165 -binding HS (HS7) could augment endogenous VEGF activity during stroke recovery without affecting blood-brain barrier function. Methods: Both rat brain endothelial cell line 4 and primary rat neural progenitor cells were used to evaluate the potential angiogenic and neurogenic effects of HS7 in vitro. For in vivo experiments, male Sprague-Dawley rats were subjected to 100 minutes of transient focal cerebral ischemia, then treated after 4 days with either PBS or HS7. One week later, infarct volume, behavioral sequelae, immunohistochemical markers of angiogenesis and neural stem cell proliferation were assessed. Results: HS7 significantly enhanced VEGF 165 -mediated angiogenesis in rat brain endothelial cell line 4 brain endothelial cells, and increased the proliferation and differentiation of primary neural progenitor cells, both via the VEGFR2 (vascular endothelial growth factor receptor 2) pathway. Intracerebroventricular injection of HS7 improved neurological outcome in ischemic rats without changing infarct volumes. Immunostaining of the compromised cerebrum demonstrated increases in collagen IV/Ki67 and nestin/Ki67 after HS7 exposure, consistent with its ability to promote angiogenesis and neurogenesis, without compromising blood-brain barrier integrity. Conclusions: A VEGF-activating glycosaminoglycan sugar, by itself, is able to enhance endogenous VEGF 165 activity during the post-ischemic recovery phase of stroke.

scholarly journals Vascular Endothelial Growth Factor Increases during Blood-Brain Barrier-Enhanced Permeability Caused byPhoneutria nigriventerSpider Venom

2014 ◽  
Vol 2014 ◽  
pp. 1-13 ◽  
Author(s):  
Monique C. P. Mendonça ◽  
Edilene S. Soares ◽  
Leila M. Stávale ◽  
Evanguedes Kalapothakis ◽  
Maria Alice Cruz-Höfling
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Ion Channels ◽  
Growth Factor ◽  
Blood Brain Barrier ◽  
Brain Barrier ◽  
Vascular Endothelial ◽  
Vegf Mrna ◽  
Blood Brain ◽  
Calbindin D28k ◽  
Endothelial Growth Factor

Phoneutria nigriventerspider accidental envenomation provokes neurotoxic manifestations, which when critical, results in epileptic-like episodes. In rats,P. nigriventervenom (PNV) causes blood-brain barrier breakdown (BBBb). The PNV-induced excitotoxicity results from disturbances on Na+, K+and Ca2+channels and glutamate handling. The vascular endothelial growth factor (VEGF), beyond its angiogenic effect, also, interferes on synaptic physiology by affecting the same ion channels and protects neurons from excitotoxicity. However, it is unknown whether VEGF expression is altered following PNV envenomation. We found that adult and neonates rats injected with PNV showed immediate neurotoxic manifestations which paralleled with endothelial occludin,β-catenin, and laminin downregulation indicative of BBBb. In neonate rats, VEGF, VEGF mRNA, and Flt-1 receptors, glutamate decarboxylase, and calbindin-D28k increased in Purkinje neurons, while, in adult rats, the BBBb paralleled with VEGF mRNA, Flk-1, and calbindin-D28k increases and Flt-1 decreases. Statistically, the variable age had a role in such differences, which might be due to age-related unequal maturation of blood-brain barrier (BBB) and thus differential cross-signaling among components of the glial neurovascular unit. The concurrent increases in the VEGF/Flt-1/Flk-1 system in the cerebellar neuron cells and the BBBb following PNV exposure might imply a cytokine modulation of neuronal excitability consequent to homeostatic perturbations induced by ion channels-acting PNV neuropeptides. Whether such modulation represents neuroprotection needs further investigation.

scholarly journals Adult human dental pulp stem cells promote blood–brain barrier permeability through vascular endothelial growth factor-a expression

2015 ◽  
Vol 36 (6) ◽  
pp. 1087-1097 ◽  
Author(s):  
Joshua N Winderlich ◽  
Karlea L Kremer ◽  
Simon A Koblar
Keyword(s):  
Stem Cells ◽  
Vascular Endothelial Growth Factor ◽  
Stem Cell ◽  
Growth Factor ◽  
Blood Brain Barrier ◽  
Dental Pulp ◽  
Brain Barrier ◽  
Vascular Endothelial ◽  
Blood Brain ◽  
Endothelial Growth Factor

Stem cell therapy is a promising new treatment option for stroke. Intravascular administration of stem cells is a valid approach as stem cells have been shown to transmigrate the blood–brain barrier. The mechanism that causes this effect has not yet been elucidated. We hypothesized that stem cells would mediate localized discontinuities in the blood–brain barrier, which would allow passage into the brain parenchyma. Here, we demonstrate that adult human dental pulp stem cells express a soluble factor that increases permeability across an in vitro model of the blood–brain barrier. This effect was shown to be the result of vascular endothelial growth factor-a. The effect could be amplified by exposing dental pulp stem cell to stromal-derived factor 1, which stimulates vascular endothelial growth factor-a expression. These findings support the use of dental pulp stem cell in therapy for stroke.

Sign in / Sign up

Export Citation Format

Share Document